• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD Back to Search Results
Catalog Number UNK ABSORB
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Myocardial Infarction (1969); Thrombosis (2100); Stenosis (2263)
Event Date 12/01/2016
Event Type  Injury  
Manufacturer Narrative
Date of event: estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Date of implant: estimated.The scaffolds remain in the patients.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The patient deaths and other adverse patient events reported are filed under separate medwatch report numbers.Literature article title: hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in (b)(6) registry.
 
Event Description
This is filed for the patient adverse events: it was reported through a research article identifying the absorb bioresorbable vascular scaffold (bvs) that may be related to: death, thrombosis, stenosis, myocardial infarction, revascularization, hospitalization and treatment with medication.Specific patient information is documented as unknown.Details are listed in the attached article, titled: "hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in (b)(6) registry.".
 
Manufacturer Narrative
The devices remain implanted and were not returned for analysis.A review of the lot history records and complaint histories could not be conducted because the lot and part numbers were not provided.The reported patient effects of thrombosis, myocardial infarction and stenosis are listed and consistent with the product risk profile and are therefore expected.A conclusive cause for the difficulties listed can not be determined based on the limited information available.The patient effects listed are consistent with the product risk profile and are therefore expected.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE SCAFFOLD
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11126846
MDR Text Key225558887
Report Number2024168-2021-00156
Device Sequence Number1
Product Code PNY
Combination Product (y/n)Y
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 01/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK ABSORB
Was Device Available for Evaluation? No
Date Manufacturer Received01/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age64 YR
-
-